|
Name |
Zelkovamycin C
|
Molecular Formula | C36H45N9O10S | |
IUPAC Name* |
(4S,7S,13R,16Z,22R)-7-acetyl-13-ethyl-16-ethylidene-4-[(5-hydroxy-4-methoxy-1H-indol-3-yl)methyl]-7,18,22-trimethyl-24-thia-3,6,9,12,15,18,21,26-octazabicyclo[21.2.1]hexacosa-1(25),23(26)-diene-2,5,8,11,14,17,20-heptone
|
|
SMILES |
CC[C@@H]1C(=O)N/C(=C\C)/C(=O)N(CC(=O)N[C@@H](C2=NC(=CS2)C(=O)N[C@H](C(=O)N[C@@](C(=O)NCC(=O)N1)(C)C(=O)C)CC3=CNC4=C3C(=C(C=C4)O)OC)C)C
|
|
InChI |
InChI=1S/C36H45N9O10S/c1-8-20-30(50)41-21(9-2)34(53)45(6)15-27(49)39-17(3)33-43-24(16-56-33)31(51)42-23(12-19-13-37-22-10-11-25(47)29(55-7)28(19)22)32(52)44-36(5,18(4)46)35(54)38-14-26(48)40-20/h9-11,13,16-17,20,23,37,47H,8,12,14-15H2,1-7H3,(H,38,54)(H,39,49)(H,40,48)(H,41,50)(H,42,51)(H,44,52)/b21-9-/t17-,20-,23+,36+/m1/s1
|
|
InChIKey |
OORNONOEAPJBHY-IXVWJLNKSA-N
|
|
Synonyms |
Zelkovamycin C
|
|
CAS | NA | |
PubChem CID | 156582955 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 795.9 | ALogp: | 0.5 |
HBD: | 8 | HBA: | 12 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 298.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 56 | QED Weighted: | 0.128 |
Caco-2 Permeability: | -5.921 | MDCK Permeability: | 0.00000367 |
Pgp-inhibitor: | 0.062 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.737 | 20% Bioavailability (F20%): | 0.99 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.099 | Plasma Protein Binding (PPB): | 77.44% |
Volume Distribution (VD): | 0.299 | Fu: | 36.94% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.109 |
CYP2C19-inhibitor: | 0.095 | CYP2C19-substrate: | 0.038 |
CYP2C9-inhibitor: | 0.233 | CYP2C9-substrate: | 0.568 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.1 |
CYP3A4-inhibitor: | 0.121 | CYP3A4-substrate: | 0.073 |
Clearance (CL): | 2.447 | Half-life (T1/2): | 0.83 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.504 |
Drug-inuced Liver Injury (DILI): | 0.824 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.667 |
Skin Sensitization: | 0.149 | Carcinogencity: | 0.018 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.003 |
Respiratory Toxicity: | 0.165 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002016 | 0.819 | D09ZIO | 0.285 | ||||
ENC004435 | 0.815 | D0X9PF | 0.246 | ||||
ENC004434 | 0.801 | D0M2YE | 0.232 | ||||
ENC004433 | 0.704 | D0L7LC | 0.232 | ||||
ENC005139 | 0.343 | D07DSQ | 0.227 | ||||
ENC005276 | 0.303 | D0E2OU | 0.223 | ||||
ENC005343 | 0.294 | D02XIY | 0.219 | ||||
ENC002515 | 0.282 | D0D8XY | 0.216 | ||||
ENC005563 | 0.275 | D02SBQ | 0.215 | ||||
ENC002514 | 0.275 | D07XGH | 0.214 |